Literature DB >> 17404763

MRI and (18)FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients.

Nadir Alexander Ghanem1, Gregor Pache, Christian Lohrmann, Ingo Brink, Thorsten Bley, Elmar Kotter, Thomas Kelly, Mathias Langer.   

Abstract

The aim of this study was to evaluate the diagnostic value of MRI and (18)FDG-PET in bone marrow infiltration of the spine due to metastases of solid tumours and lymphoma in cancer patients. In 35 cancer patients (solid tumours n = 26, lymphoma n = 9) MRI of the spine and (18)FDG-PET were reviewed and the detectability of metastases, infiltration of the spine, extent of disease, and therapeutic implications were compared. In 8/35 cases (23%) imaging technique showed concordantly no bone marrow infiltration. In 19/35 patients (54%), both MRI and (18)FDG-PET revealed bone marrow infiltration of the axial skeleton. In 12/19 patients (63%), MRI showed more extensive disease which lead to subsequent therapy. The imaging findings of MRI and (18)FDG-PET were discordant in 8/35 cases (23%). (18)FDG-PET was false positive in two patients. In six patients, (18)FDG-PET failed to detect bone metastases and bone marrow infiltration of the spine, which was detected by MRI and proven by clinical follow-up with subsequent therapy in two cases. MRI is more sensitive and specific than (18)FDG-PET detecting bone marrow metastases and infiltration of the spine and has a great impact in staging cancer patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404763      PMCID: PMC2223344          DOI: 10.1007/s00586-007-0350-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  19 in total

1.  Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

Authors:  Andrea Baur; Axel Stäbler; Dorothea Nagel; Rolf Lamerz; Reiner Bartl; Erhard Hiller; Clemens Wendtner; Fridleif Bachner; Maximilian Reiser
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

2.  Breast cancer with skeletal metastases at initial diagnosis. Distinctive clinical characteristics and favorable prognosis.

Authors:  M M Sherry; F A Greco; D H Johnson; J D Hainsworth
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

3.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Authors:  H E Daldrup-Link; C Franzius; T M Link; D Laukamp; J Sciuk; H Jürgens; O Schober; E J Rummeny
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

4.  Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.

Authors:  H Schirrmeister; A Guhlmann; J Kotzerke; C Santjohanser; T Kühn; R Kreienberg; P Messer; K Nüssle; K Elsner; G Glatting; H Träger; B Neumaier; C Diederichs; S N Reske
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

5.  FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.

Authors:  C Franzius; H E Daldrup-Link; A Wagner-Bohn; J Sciuk; W L Heindel; H Jürgens; O Schober
Journal:  Ann Oncol       Date:  2002-01       Impact factor: 32.976

6.  FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.

Authors:  C Franzius; J Sciuk; H E Daldrup-Link; H Jürgens; O Schober
Journal:  Eur J Nucl Med       Date:  2000-09

7.  Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.

Authors:  C Altehoefer; N Ghanem; S Högerle; E Moser; M Langer
Journal:  Eur J Radiol       Date:  2001-10       Impact factor: 3.528

8.  Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.

Authors:  I Brink; T Schumacher; M Mix; S Ruhland; E Stoelben; W Digel; M Henke; N Ghanem; E Moser; E U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-17       Impact factor: 9.236

9.  Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton.

Authors:  Nadir Ghanem; Carsten Altehoefer; Stefan Högerle; Oliver Schäfer; Jan Winterer; Ernst Moser; Mathias Langer
Journal:  Eur J Radiol       Date:  2002-09       Impact factor: 3.528

10.  Sacral fractures: a potential pitfall of FDG positron emission tomography.

Authors:  Laura M Fayad; Christian Cohade; Richard L Wahl; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2003-11       Impact factor: 3.959

View more
  8 in total

Review 1.  A survey of the "medical" articles in the European Spine Journal, 2007.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2008-01-08       Impact factor: 3.134

2.  Skeletal metastases: what is the future role for nuclear medicine?

Authors:  Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11       Impact factor: 9.236

3.  Whole-body MRI in patients with lymphoma: collateral findings.

Authors:  Massimo Galia; Domenico Albano; Donatella Narese; Caterina Patti; Vito Chianca; Francesco Di Pietto; Antonino Mulè; Emanuele Grassedonio; Ludovico La Grutta; Roberto Lagalla; Massimo Midiri
Journal:  Radiol Med       Date:  2016-06-15       Impact factor: 3.469

Review 4.  Current molecular imaging of spinal tumors in clinical practice.

Authors:  Nora Sandu; Gabriele Pöpperl; Marie-Elisabeth Toubert; Toma Spiriev; Belachew Arasho; Mikael Orabi; Bernhard Schaller
Journal:  Mol Med       Date:  2011-01-03       Impact factor: 6.354

5.  Detection of vertebral metastases: a comparison between the modified Dixon turbo spin echo T2 weighted MRI and conventional T1 weighted MRI: a preliminary study in a tertiary centre.

Authors:  Seok Hahn; Young Han Lee; Jin-Suck Suh
Journal:  Br J Radiol       Date:  2018-03-15       Impact factor: 3.039

6.  Bone and marrow imaging: do we know what we see and do we see what we want to know?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07       Impact factor: 10.057

7.  Non-contrast-enhanced whole-body magnetic resonance imaging in the general population: the incidence of abnormal findings in patients 50 years old and younger compared to older subjects.

Authors:  Andrzej Cieszanowski; Edyta Maj; Piotr Kulisiewicz; Ireneusz P Grudzinski; Karolina Jakoniuk-Glodala; Irena Chlipala-Nitek; Bartosz Kaczynski; Olgierd Rowinski
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

8.  The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma.

Authors:  Vincent W C Wu; Wan-Shun Leung; Kwun-Lam Wong; Ying-Kit Chan; Wing-Lam Law; Wing-Kwan Leung; Yat-Long Yu
Journal:  Radiat Oncol       Date:  2016-08-24       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.